Coronavirus
China’s Sinopharm says second-generation COVID-19 vaccine approved for trial
China National Pharmaceutical Group Co. said its second-generation recombinant protein COVID-19 vaccine has received approval from Beijing for clinical trials.
Better known as Sinopharm, the state-owned enterprise’s vaccine-developing unit, China National Biotec Group, announced the news on its WeChat account on Sunday.
Read the latest updates in our dedicated coronavirus section.
The improved vaccine has already been approved by the United Arab Emirates as a booster shot and enhances immune response to the coronavirus, the company said in December.
For the latest headlines, follow our Google News channel online or via the app.
China is currently grappling with its worst infection outbreak since the early days of the pandemic, reporting more than 13,000 new COVID-19 cases on Sunday.
Vice Premier Sun Chunlan arrived in the country’s virus hotspot of Shanghai to oversee prevention efforts, as she ordered officials to curtail the outbreak “as soon as possible, according to Xinhua.
Cases in the financial hub exceeded 8,000 on Saturday including 7,788 asymptomatic infections.
Shanghai will start a new round of mass testing on Monday, authorities said.
Read more:
Shanghai separates COVID-positive children from parents in virus fight
China continues ‘severe and complex’ fight against COVID-19
WHO suspends procurement, supply of Bharat Biotech COVID vaccine citing deficiencies
Also Read
-
Sinopharm protein booster stronger against omicron than earlier shot: Abu Dhabi study
An Abu Dhabi-led study has shown that a protein-based COVID-19 vaccine made by Sinopharm, when given as a booster shot, after two doses of an earlier ... Coronavirus -
UAE approves Sinopharm’s protein-based vaccine as a booster dose
The United Arab Emirates has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster ... Coronavirus -
UK COVID-19 rules updated to recognize UAE travelers with Sinopharm, Sinovac
The United Kingdom has updated its COVID-19 travel rules, approving travelers who have had the Chinese-made Sinopharm or Sinovac vaccines into the ... Coronavirus -
Explainer: What is the new UAE-approved Sinopharm protein vaccine?
The United Arab Emirates has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster ... Coronavirus -
WHO suspends procurement, supply of Bharat Biotech COVID vaccine citing deficiencies
The World Health Organization suspended procurement and supply of Covaxin, a Covid-19 vaccine made by Bharat Biotech International Ltd., citing issues ... Coronavirus -
COVID-19 pandemic is ‘far from over’: WHO official
A World Health Organization spokesperson said on Friday that the end of the COVID-19 pandemic was a long way off, citing a rise in cases in its latest ... Coronavirus
